Press "Enter" to skip to content

New patent for NOVO drug SAXENDA

0
Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug SAXENDA

Annual Drug Patent Expirations for SAXENDA
Annual Drug Patent Expirations for SAXENDA

Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are nineteen patents protecting this drug.

SAXENDA drug price trends.

Drug patent litigation for SAXENDA.

This drug has two hundred and thirty-seven patent family members in twenty-seven countries.

The generic ingredient in SAXENDA is liraglutide recombinant. One supplier is listed for this compound. Additional details are available on the liraglutide recombinant profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for NOVO drug SAXENDA
    Do NOT follow this link or you will be banned from the site!